kevinemmetfoley.com → stock → market stock close → what are warrants in the stock market
Posted on by Bruce Wise

What Are Warrants in the Stock Market

Illustration of a stock warrant certificate with a company logo and strike price details

Warrants are financial instruments issued by a company that grant the holder the right to purchase its common stock at a predetermined price before a specified expiration date. Unlike options, which are traded on exchanges and created by third parties, warrants are issued directly by the company and often come with long-term maturities-sometimes lasting years.

When a company issues warrants, it typically does so to raise capital. The investor pays a premium to receive the right to buy shares later at a fixed price, known as the exercise or strike price. If the stock trades above that price, the warrant becomes valuable. Warrants are traded on major exchanges and can be bought and sold independently of the underlying stock.

The concept dates back to the 19th century, but modern warrant issuance gained traction during the dot-com boom and has since been used in IPOs, private placements, and debt financing. According to the Securities and Exchange Commission (SEC), warrants are registered securities under the Securities Act of 1933 and must be disclosed in offering documents.

How Warrants Work

Warrants function similarly to call options but differ in origin and structure. A warrant gives the holder the right-but not the obligation-to buy a specific number of shares at a set price within a defined time frame. The exercise price is usually set above the current market price at issuance, making the warrant initially out-of-the-money.

For example, Company X issues warrants with a strike price of $50 per share. At issuance, the stock trades at $45. The warrant allows the holder to buy shares at $50 anytime before expiry. If the stock rises to $65, the warrant has intrinsic value: $15 per share. The holder can exercise the warrant, pay $50 per share, and immediately sell the shares for $65, capturing a $15 profit per share.

When a warrant is exercised, the company issues new shares. This increases the total number of outstanding shares, diluting existing shareholders' ownership. The dilution effect is a key risk for current investors. For instance, if a company with 1 million shares outstanding issues 100,000 warrants and they are all exercised, the total shares rise to 1.1 million-reducing each shareholder's percentage stake by approximately 9%.

Types of Warrants

Warrants fall into two primary categories based on their structure and purpose:

Type Description Example
Call Warrants Give the right to buy shares at a fixed price. Most common type. Netflix issued call warrants in 2008 to fund expansion.
Put Warrants Give the right to sell shares at a fixed price. Rare and typically used in structured products. Used in some bond offerings to provide downside protection.

Most warrants are call warrants tied to equity. Put warrants are uncommon because companies rarely issue them-instead, investors use put options on exchanges to hedge downside risk.

Another distinction is between naked and covered warrants. Naked warrants are issued without collateral backing, relying solely on the issuer's creditworthiness. Covered warrants are backed by an equivalent amount of underlying shares held in reserve. Covered warrants are less risky for investors but require more complex accounting and regulatory oversight.

Why Companies Issue Warrants

Companies issue warrants primarily to attract investment. By attaching warrants to bonds or preferred stock, firms offer potential upside to investors, lowering the cost of capital. For example, a company issuing $10 million in convertible notes might attach warrants allowing investors to buy shares at a 20% discount to the current market price.

This strategy was widely used during the 1980s stock market boom. As documented in *The New York Times* archives, many tech startups in the late 1980s bundled warrants with venture capital deals to compensate for high risk. These warrants helped early-stage firms secure funding without immediate equity dilution.

Warrants also serve as employee compensation tools. Startups often grant stock options or warrants to founders and staff as part of hiring packages. The value grows if the company's stock appreciates, aligning incentives. However, these are typically not publicly traded and are subject to vesting schedules.

Common Misconceptions and Key Distinctions

Many confuse warrants with options. While both are derivative instruments giving the right to buy or sell stock, options are standardized contracts traded on exchanges and created by clearinghouses. Warrants are issued directly by companies and are not standardized. Their terms are negotiated and vary widely.

A critical difference lies in liquidity and trading volume. Options have high turnover and tight bid-ask spreads. Warrants often trade thinly, especially those issued by smaller firms. A 2021 study by the Journal of Financial Economics found that warrants with low trading volume had average bid-ask spreads exceeding 15%, compared to less than 1% for standard exchange-traded options.

Another misconception is that warrants always increase shareholder value. In reality, they can reduce per-share earnings due to dilution. When warrants are exercised, the company issues new shares, increasing the float. This can pressure the stock price if demand doesn't keep pace. Dell Inc. faced this issue in 2003 when a large number of warrants were exercised, contributing to a 12% drop in share price over six months despite strong revenue growth.

Warrants are not likely to be profitable. If the stock never trades above the strike price, the warrant expires worthless. Investors who bought warrants in Tesla's 2010 IPO at a $50 strike price saw little return until 2013, when the stock surpassed $100. Those who held through the volatility realized gains, but many lost money due to poor timing or lack of diversification.

Real-World Example: Warrants in Action

In 2017, a biotech firm, BioNova Therapeutics, raised $50 million through a private placement. The offering included $25 million in senior notes and $25 million in detachable warrants. Each $1,000 note came with 100 warrants to buy common stock at $20 per share, valid for five years.

At issuance, BioNova's stock traded at $18. The warrants were out-of-the-money but offered use. Over the next three years, the company secured FDA approval for its lead drug. The stock surged to $45. Holders exercised 80% of the warrants, buying 200,000 new shares at $20 each. The company received $4 million in cash, and the stock rose further to $52.

After exercise, the total shares outstanding increased from 10 million to 10.2 million-a 2% dilution. Shareholders saw a modest reduction in ownership, but the value of the company grew. The warrants acted as a catalyst for investor participation and capital formation.

As noted by the SEC in Regulation S-K, companies must disclose the impact of warrant exercises on diluted earnings per share. Failure to do so can result in enforcement actions. In 2019, a small-cap firm was fined $250,000 for omitting warrant dilution effects in its annual filing.

Final Thoughts

Warrants in the stock market are tools for raising capital and incentivizing investment. They allow companies to offer long-term upside to investors while deferring equity issuance. However, they carry risks-especially dilution and volatility-that investors must assess carefully.

Warrants are not speculative toys. They are formal securities with legal and financial consequences. When evaluating a warrant, examine the strike price, expiration date, and the company's history of issuing new shares. Doing so separates informed decisions from blind bets.


Related Posts